Janssen Liability Increased to $1.6 Billion in Drug Fraud Suit
Janssen Products LP must pay over $1.6 billion in a False Claims Act suit for improperly billing the US government for HIV ...
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
J&J Win Blocking Mylan Schizophrenia Treatment Upheld on Appeal
Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit convinced a federal appeals court Mylan Laboratories Ltd.’s planned ...
Lupin shares rise nearly 3% on launch of Rivaroxaban Tablets USP, in the US
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto Tablets, 2.5 mg, meaning it has the same active ingredient, ...
pharmaphorum21d
Janssen Pharmaceutical exclusive interview released ahead of Pre-filled Syringes East Coast
SMi Reports: Alie Jahangir from Janssen Pharmaceutical to speak at Pre-Filled ... be focusing on new stability paradigm for combination products, including PFS as single-entity CP/ The major ...